Unmet Needs in Treating Relapsed/Refractory FL
Laurie Sehn, MD, and Bijal Shah, MD, discuss remaining unmet needs for patients with relapsed/refractory FL.
Source: onclive.com
Stay updated with breaking news from Pod 24. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Laurie Sehn, MD, and Bijal Shah, MD, discuss remaining unmet needs for patients with relapsed/refractory FL.
Peter Martin, MD, discusses recent data on tazemetostat, an EZH2 inhibitor, as third-line and beyond therapy for FL.
Bijal Shah, MD, discusses recent data on CAR T-cell therapy as third-line and beyond treatment for FL.